RANKING OF IN-VIVO (31)PHOSPHORUS SPECTRO SCOPY IN THE DIAGNOSIS OF GENERALIZED MUSCLE DISORDERS - CLINICAL-RESULTS AND DIFFERENTIAL DIAGNOSTIC ASPECTS
Tj. Vogl et al., RANKING OF IN-VIVO (31)PHOSPHORUS SPECTRO SCOPY IN THE DIAGNOSIS OF GENERALIZED MUSCLE DISORDERS - CLINICAL-RESULTS AND DIFFERENTIAL DIAGNOSTIC ASPECTS, RoFo. Fortschritte auf dem Gebiete der Rontgenstrahlen und der neuenbildgebenden Verfahren, 162(6), 1995, pp. 455-463
Purpose: In a prospective study, characteristics and the diagnostic po
tential of in vivo (31)phosphorus spectroscopy in cases of generalised
muscle diseases were analysed. Method: 41 patients with myogenic and
neurogenic muscle diseases and 11 healthy volunteers were examined usi
ng MRI and in vivo-(31)phosphorus spectroscopy by means of a 50 mm dou
ble-tuned surface coil. Results: The spectra showed significant change
s of the metabolite ratios depending on the degree of the disease. Inf
lammatory muscle diseases were characterised by increased PME and PDE
peaks, which indicates that there is a higher conversion of the cell m
embrane. The spectra of muscular dystrophy showed a slight increase of
PDE and Pi. A strongly reduced PCr and an increased Pi peak were demo
nstrated in cases of muscle atrophy depending on their degree of marke
dness. The pH values were minimally increased in comparison to the vol
unteers. In other muscle diseases, such as glycogenosis or myotonia, n
o significant changes were detected. Conclusion: Standardised in vivo
(31)phosphorus spectroscopy of generalised muscle diseases provides no
ninvasive prognostic information on the type and behaviour of the dise
ase and is complementary to clinical and histological findings.